Outcomes following definitive stereotactic body radiotherapy for patients with Child-Pugh B or C hepatocellular carcinoma

Radiotherapy and Oncology

Volumn 111, Issue 3, 2014, Pages 412-417

  Culleton, Shaelyn ^a,b   Jiang, Haiyan ^a   Haddad, Carol R ^a,b   Kim, John ^a,b   Brierley, Jim ^a,b   Brade, Anthony ^a,b   Ringash, Jolie ^a,b   Dawson, Laura A ^a,b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Child Pugh B; Hepatocellular carcinoma; SBRT; Stereotactic body radiotherapy

Indexed keywords

ALPHA FETOPROTEIN; AMINOTRANSFERASE;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ACUTE TOXICITY; ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CAUCASIAN; CHILD PUGH SCORE; CLINICAL ARTICLE; DIARRHEA; FATIGUE; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; HYPERBILIRUBINEMIA; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER FUNCTION; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PORTAL VEIN THROMBOSIS; PORTAL VEIN TUMOR THROMBOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION INDUCED EMESIS; RADIATION INJURY; STEREOTACTIC BODY RADIATION THERAPY; SURVIVAL RATE; THROMBOCYTOPENIA; TUMOR THROMBUS; TUMOR VOLUME; LIVER TRANSPLANTATION; NAUSEA; RADIATION DOSE FRACTIONATION; TREATMENT OUTCOME; VOMITING;

CHILD-PUGH B; HEPATOCELLULAR CARCINOMA; SBRT; STEREOTACTIC BODY RADIOTHERAPY;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RADIOSURGERY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84905257860     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2014.05.002     Document Type: Article

References (23)

1. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, and D.M. Parkin Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer 127 2010 2893 2917
2. Canadian Cancer Society's Steering Committee on Cancer Statistics Canadian cancer statistics 2012 2012 Canadian Cancer Society Toronto (ON)
3. M.B. Thomas, D. Jaffe, M.M. Choti, J. Belghiti, S. Curley, and Y. Fong et al. Hepatocellular carcinoma: consensus recommendations of the national cancer institute clinical trials planning meeting J Clin Oncol 28 2010 3994 4005
4. M. Peck-Radosavljevic Hepatocellular carcinoma: the place of new medical therapies Therap Adv Gastroenterol 3 2010 259 267
5. L. Rimassa, and A. Santoro Sorafenib therapy in advanced hepatocellular carcinoma: the SHARP trial Expert Rev Anticancer Ther 9 2009 739 745
6. A. Bujold, C. Massey, J.J. Kim, J.D. Brierley, R. Wong, and C. Cho et al. Outcomes following sequential trials of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma J Clin Oncol 29 2011 4111
7. H.R. Cardenes, T.R. Price, S.M. Perkins, M. Maluccio, P. Kwo, and T.E. Breen et al. Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma Clin Translat Oncol 12 2010 218 225
8. Mendez Romero A, Wunderink W, van Os RM, Nowak PJ, Heijmen BJ, Nuyttens JJ, et al. Quality of life after stereotactic body radiation therapy for primary and metastatic liver tumors. Int J Radiat Oncol Biol Phys 2008;70:1447-52. (Pubitemid 351417765)
9. R.V. Tse, M. Hawkins, G. Lockwood, J.J. Kim, B. Cummings, and J. Knox et al. Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma J Clin Oncol 26 2008 657 664 (Pubitemid 351264363)
10. A. Bujold, and L.A. Dawson Stereotactic radiation therapy and selective internal radiation therapy for hepatocellular carcinoma Cancer Radiother 15 2011 54 63
11. Sanuki N, Takeda A, Oku Y, Mizuno T, Aoki Y, Eriguchi T, et al. Stereotactic body radiotherapy for small hepatocellular carcinoma: a retrospective outcome analysis in 185 patients. Acta Oncol 2013; Epub ahead of print.
12. National Cancer Institute. Common terminology criteria for adverse events v4.0. NIH, Publication # 09-7473 2009.
13. E.A. Eisenhauer, P. Therasse, J. Bogaerts, L.H. Schwartz, D. Sargent, and R. Ford et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur J Cancer 45 2009 228 247
14. L.A. Dawson, C. Eccles, and T. Craig Individualized image guided iso-NTCP based liver cancer SBRT Acta Oncol 45 2006 856 864 (Pubitemid 44423132)
15. M. Pintilie Analysing interpreting competing risk data Stat Med 26 2007 1360 1367 (Pubitemid 46380846)
16. J.P. Fine, and R.J. Gray A proportional hazards model for the subdistribution of a competing risk J Am Stat Assoc 94 1999 496 509
17. A. Hollebecque, S. Cattan, O. Romano, G. Sergent, A. Mourad, and A. Louvet et al. Safety and efficacy of sorafenib in hepatocellular carcinoma: the impact of the child-pugh score Aliment Pharmacol Ther 34 2011 1193 1201
18. W.Y. Huang, Y.M. Jen, M.S. Lee, L.P. Chang, C.M. Chen, and K.H. Ko et al. Stereotactic body radiation therapy in recurrent hepatocellular carcinoma Int J Radiat Oncol Biol Phys 84 2012 355 361
19. Marrero JA, Lencloni R, Kudo M, et al. Global investigation of therapeutic decisions in hepatocellular carcinoma and of its treatment with Sorafenib (GIDEON) second interim analysis in more than 1,500 patients: clinical findings in patients with liver dysfunction. 2011 ASCO Annual Meeting. Abstract 4001. Presented June 7, 2011.
20. T. Nakazawa, S. Adachi, M. Kitano, Y. Isobe, S. Kokubu, and H. Hidaka et al. Potential prognostic benefits of radiotherapy as an initial treatment for patients with unresectable advanced hepatocellular carcinoma with invasion to intrahepatic large vessels Oncology 73 2007 90 97 (Pubitemid 351465606)
21. K. Uchino, R. Tateishi, S. Shiina, M. Kanda, R. Masuzaki, and Y. Kondo et al. Hepatocellular carcinoma with extrahepatic metastases: clinical features and prognostic factors Cancer 117 2011 4475 4483
22. Y. Seo, J. Kim, B. Keum, S. Park, Y. Kwon, and Y. Kim et al. Radiotherapy for 65 patients with advanced unresectable hepatocellular carcinoma World J Gastroenterol 14 2008 2394 2400 (Pubitemid 351877612)
23. Dionisi F, Widescott L, Lorentini S, Amichetti M. Is there a role for proton therapy in the treatment of hepatocellular carcinoma? A systematic review. Radiother Oncol 2014. Epub ahead of Print.